Content delivery services provider Cloudflare has blamed US telco Verizon Communications Inc. (NYSE:VZ) for a large-scale border gateway protocol leak on Monday night (Australian time) that caused many large sites to be inaccessible. Cloudflare’s Tom Strickx said in a blog post that the problem had been magnified by the involvement of a so-called BGP optimiser product from a company known as Noction. The problems began at about 10:30 UTC (8.30pm Monday night AEST) and were sorted two hours later.
Verizon Communications Inc. (NYSE:VZ), a Technology sector firm, traded 8.88 Million shares in last trading session with closing price of $58.27 per share. Company gross margin stands at 58.10% whereas its return on investment (ROI) is 12.10%. Stock value has moved between $48.97 – 61.34 in last one year. Analyst’s mean target price for Verizon Communications Inc. (NYSE:VZ) is $59.71 while analysts mean recommendation is 2.50. VZ EPS growth this year is 15.20%.
On last trading day, Helen of Troy Limited (NASDAQ:HELE) shares closed at $135.42 per share. HELE market capitalization is 3407.17 with beta of 0.73. Analyst’s mean target price for Helen of Troy Limited (NASDAQ:HELE) is $155.80 whereas analysts mean recommendation is 1.80. Its weekly performance is -0.65% while year to date (YTD) performance is 3.23%.
In last session Precision Drilling Corporation (NYSE:PDS) traded 722794 shares and was closed at $1.81. Analyst’s mean target price for PDS is $4.44 while analysts mean recommendation is 1.90. Company is -56.07% away from its 52 week high and is moving 11.73% ahead of its 52 week low. PDS Gross Margin is 31.30% and its return on assets is -6.70%. Precision Drilling Corporation (NYSE:PDS) quarterly performance is -24.90% while its price to sale ratio is 0.45.
Blueprint Medicines Corporation (NASDAQ:BPMC), a Healthcare sector firm, traded 396997 shares on last trading day with closing price of $92.82 per share. Company return on investment (ROI) is -59.00%. Stock value has moved between $44.63 – 100.89 in last one year. Analyst’s mean target price for Blueprint Medicines Corporation (NASDAQ:BPMC) is $109.38 while analysts mean recommendation is 1.40. BPMC EPS growth this year is -37.60%.
